CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2021;27(2):273-277. Published online 2021 February 1 DOI: https://doi.org/10.3350/cmh.2021.0019

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong

Clinical and Molecular Hepatology. 2021;27(2):273-277

Link1

Link2 Link3

Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B

Mayur Gattani, Meghraj Ingle, Shamshersingh Chauhan, Saiprasad Lad

Alimentary Pharmacology & Therapeutics. 2020;52(5):911-912

Link1 Link2

Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors’ reply

Han Ah Lee, Seung Up Kim

Alimentary Pharmacology & Therapeutics. 2020;52(5):913-914

Link1 Link2

Are the Patients in the Immune Tolerant Phase of Chronic Hepatitis B far from Hepatocellular Carcinoma or Death?

Nae-Yun Heo

The Korean Journal of Gastroenterology. 2019;74(1):66

Link1 Link2 Link3

Comparable risk of hepatocellular carcinoma between immune-tolerant and active phase in hepatitis B e antigen-positive patients

Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Chai Hong Rim

Journal of Hepatology. 2022;77:S283-S284

Link1 Link2

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B

Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clinical and Molecular Hepatology. 2021;27(2):295-304

Link1

Link2 Link3

THU-231-Risk of hepatocellular carcinoma in patients with immune-tolerant chronic hepatitis B

Gyeol Seong, Dong Hyun Sinn, Wonseok Kang, Geum-Yon Gwak, Moon Seok Choi, Kwang Cheol Koh, Seoung Woon Paik, Yong Han Paik

Journal of Hepatology. 2019;70(1):e266-e267

Link1 Link2

Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis

A. D. ENRIQUEZ, M. S. CAMPBELL, K. R. REDDY

Alimentary Pharmacology & Therapeutics. 2007;26(3):383-391

Link1 Link2

Nucleos(T)Ide Analogue Treatment for Immune Tolerant Phase of Chronic Hepatitis B Patients Prolongs Overall Survival and Reduces the Risk of Hepatocellular Carcinoma and Cirrhosis: A Real-Life Study

Y. Chang, J.-H. Lee, J.Y. Nam, H. Ahn, H. Cho, Y. Cho, Y.Y. Cho, J.-J. Yoo, M. Lee, D.H. Lee, E.J. Cho, S.J. Yu, Y.J. Kim, J.-H. Yoon

Journal of Hepatology. 2016;64(2):S162

Link1 Link2

O113: Association of the −515A>G CDC6 polymorphism with risk to develop hepatocellular carcinoma in patients with chronic hepatitis C

Journal of Viral Hepatitis. 2014;21:3-4

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.